These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 22958921)

  • 41. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
    Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y
    J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FGF21 Mediates the Thermogenic and Insulin-Sensitizing Effects of Dietary Methionine Restriction but Not Its Effects on Hepatic Lipid Metabolism.
    Wanders D; Forney LA; Stone KP; Burk DH; Pierse A; Gettys TW
    Diabetes; 2017 Apr; 66(4):858-867. PubMed ID: 28096260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice.
    Holland WL; Adams AC; Brozinick JT; Bui HH; Miyauchi Y; Kusminski CM; Bauer SM; Wade M; Singhal E; Cheng CC; Volk K; Kuo MS; Gordillo R; Kharitonenkov A; Scherer PE
    Cell Metab; 2013 May; 17(5):790-7. PubMed ID: 23663742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.
    Sarruf DA; Thaler JP; Morton GJ; German J; Fischer JD; Ogimoto K; Schwartz MW
    Diabetes; 2010 Jul; 59(7):1817-24. PubMed ID: 20357365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
    Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
    Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
    Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
    Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
    Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
    Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fgf21 impairs adipocyte insulin sensitivity in mice fed a low-carbohydrate, high-fat ketogenic diet.
    Murata Y; Nishio K; Mochiyama T; Konishi M; Shimada M; Ohta H; Itoh N
    PLoS One; 2013; 8(7):e69330. PubMed ID: 23874946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 Action.
    Zhang J; Gupte J; Gong Y; Weiszmann J; Zhang Y; Lee KJ; Richards WG; Li Y
    EBioMedicine; 2017 Feb; 15():173-183. PubMed ID: 28041926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FGF21 signaling in glutamatergic neurons is required for weight loss associated with dietary protein dilution.
    Flippo KH; Jensen-Cody SO; Claflin KE; Potthoff MJ
    Sci Rep; 2020 Nov; 10(1):19521. PubMed ID: 33177640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dietary Methionine Restriction Signals to the Brain Through Fibroblast Growth Factor 21 to Regulate Energy Balance and Remodeling of Adipose Tissue.
    Forney LA; Fang H; Sims LC; Stone KP; Vincik LY; Vick AM; Gibson AN; Burk DH; Gettys TW
    Obesity (Silver Spring); 2020 Oct; 28(10):1912-1921. PubMed ID: 32959519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibroblast growth factor-21 (FGF21) administration to early-lactating dairy cows. I. Effects on signaling and indices of insulin action.
    Krumm CS; Giesy SL; Caixeta LS; Perfield JW; Sauerwein H; Moore BL; Boisclair YR
    J Dairy Sci; 2019 Dec; 102(12):11586-11596. PubMed ID: 31548053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho.
    Kharitonenkov A; Dunbar JD; Bina HA; Bright S; Moyers JS; Zhang C; Ding L; Micanovic R; Mehrbod SF; Knierman MD; Hale JE; Coskun T; Shanafelt AB
    J Cell Physiol; 2008 Apr; 215(1):1-7. PubMed ID: 18064602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential roles of fibroblast growth factor 21 in the brain.
    Sa-Nguanmoo P; Chattipakorn N; Chattipakorn SC
    Metab Brain Dis; 2016 Apr; 31(2):239-48. PubMed ID: 26738728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibroblast growth factor-21 improves insulin action in nonlactating ewes.
    Lamb CL; Giesy SL; McGuckin MM; Perfield JW; Butterfield A; Moniruzzaman M; Haughey NJ; McFadden JW; Boisclair YR
    Am J Physiol Regul Integr Comp Physiol; 2022 Mar; 322(3):R170-R180. PubMed ID: 35018810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases.
    Zhao L; Niu J; Lin H; Zhao J; Liu Y; Song Z; Xiang C; Wang X; Yang Y; Li X; Mohammadi M; Huang Z
    EBioMedicine; 2019 Oct; 48():462-477. PubMed ID: 31631034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors.
    Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y
    J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity.
    Agrawal A; Parlee S; Perez-Tilve D; Li P; Pan J; Mroz PA; Kruse Hansen AM; Andersen B; Finan B; Kharitonenkov A; DiMarchi RD
    Mol Metab; 2018 Jul; 13():45-55. PubMed ID: 29789271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.